82 related articles for article (PubMed ID: 2967909)
1. The endocrinology of extrapyramidal system disorders.
Kirkpatrick B; Tamminga CA
Neurol Clin; 1988 Feb; 6(1):159-72. PubMed ID: 2967909
[TBL] [Abstract][Full Text] [Related]
2. The endocrinology of extrapyramidal system disorders.
Kirkpatrick B; Tamminga CA
Endocrinol Metab Clin North Am; 1988 Mar; 17(1):159-72. PubMed ID: 2967753
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea.
Murri L; Iudice A; Muratorio A; Polleri A; Barreca T; Murialdo G
Eur Neurol; 1980; 19(3):198-206. PubMed ID: 6446454
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease, Huntington's disease and tardive dyskinesia. Neurochemical pathology and treatment.
Tolosa ES
Minn Med; 1979 Feb; 62(2):101-6. PubMed ID: 155195
[No Abstract] [Full Text] [Related]
5. Clozapine therapy for Parkinson's disease and other movement disorders.
Pfeiffer C; Wagner ML
Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
Jeste DV; Neckers LM; Wagner RL; Wise CD; Staub RA; Rogol A; Potkin SG; Bridge TP; Wyatt RJ
J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.
Fabbrini G; Braun A; Mouradian MM; Tamminga CA; Chase TN
J Neural Transm; 1988; 71(3):159-63. PubMed ID: 2965754
[TBL] [Abstract][Full Text] [Related]
8. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic dysfunction in Parkinson's disease patients.
Otake K; Oiso Y; Mitsuma T; Hirooka Y; Adachi K
Acta Med Hung; 1994; 50(1-2):3-13. PubMed ID: 7638039
[TBL] [Abstract][Full Text] [Related]
10. Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy.
Schaefer S; Vogt T; Nowak T; Kann PH;
J Neuroendocrinol; 2008 Jan; 20(1):104-9. PubMed ID: 18081558
[TBL] [Abstract][Full Text] [Related]
11. Serum prolactin levels in Parkinson's disease and multiple system atrophy.
Winkler AS; Landau S; Chaudhuri KR
Clin Auton Res; 2002 Oct; 12(5):393-8. PubMed ID: 12420085
[TBL] [Abstract][Full Text] [Related]
12. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
Caraceni T; Panerai AE; Paratl EA; Cocchi D; Müller EE
J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
[TBL] [Abstract][Full Text] [Related]
13. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
14. Normal CAG and CCG repeats in the Huntington's disease genes of Parkinson's disease patients.
Rubinsztein DC; Leggo J; Goodburn S; Barton DE; Ferguson-Smith MA
Am J Med Genet; 1995 Apr; 60(2):109-10. PubMed ID: 7485243
[TBL] [Abstract][Full Text] [Related]
15. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
Müller T; Welnic J; Woitalla D; Muhlack S
Neurosci Lett; 2007 Jul; 422(2):119-22. PubMed ID: 17590511
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist.
Tamminga CA; Neophytides A; Chase TN; Frohman LA
J Clin Endocrinol Metab; 1978 Dec; 47(6):1348-51. PubMed ID: 162520
[TBL] [Abstract][Full Text] [Related]
18. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
Fenney A; Jog MS; Duval C
Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
[TBL] [Abstract][Full Text] [Related]
19. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
[TBL] [Abstract][Full Text] [Related]
20. Prolactin response in tardive dyskinesia.
Wolf ME; Bowie L; Keener S; Mosnaim AD
Biol Psychiatry; 1982 Apr; 17(4):485-90. PubMed ID: 7082714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
